2023-03-17: Individual consultation for HIT/MCAS sufferers
The author of the SIGHI websites, Heinz Lamprecht, now offers individual consultation on the topics of histamine intolerance (HIT) and mast cell activation disorders (MCAD). Whether it be an in-person consultation or from a distance. For more information, please visit the Contact page.
Treatment of COVID-19 (Coronavirus) in MCAD / Histaminosis
The coronavirus (SARS-CoV-2) and the disease it causes called COVID-19 are still new. In the following information sheet, which is continuously updated, we summarize our current state of knowledge about the therapy of COVID-19 for those concerned with mast cell activation diseases (MCAD), mast cell activation syndrome (MCAS), mastocytosis or histamine intolerance (HIT):
|Therapy of COVID-19 (Coronavirus) in MCAS,HIT.pdf|
(356 KB, version 2021-09-09)
New edition of the SIGHI Medication Manual
The SIGHI Medication Manual has been fundamentally revised. With over 120 pages, the new August 2018 edition is about twice as comprehensive as the previous version. In addition to a description of the contents, you will now also find a freely accessible excerpt in PDF format, where you can browse the table of contents and read some pages. Both affected persons and specialists can inform themselves very broadly, independently and neutrally about the numerous possibilities of how histamine and mast cell activation symptoms can be controlled. Be it with drugs, dietary supplements or other therapies.
The SIGHI Medication Guide is now also available in English.
DAOSIN also available for non-members
New Website about MCAD: mastzellaktivierung.info
On the old SIGHI-site the two themes mast cell activation disorders (MCAD) and histamine intolerance (HIT) were mixed up too much. The MCAD (enhanced release of histamine and other mediators) has now been outsourced to a dedicated website mastzellaktivierung.info. The previous site histaminintoleranz.ch will now focus on histamine degradation disorders. It comes with a new design and a new logo.
In addition to the very rare systemic mastocytosis (SM), mast cell activation disorders (MCAD) also include the very common mast cell activation syndrome (MCAS), which, however, does not meet the diagnostic criteria of mastocytosis. Therefore, it is often overlooked. Many histamine sensitive people were mistakenly diagnosed as “histamine intolerant (HIT)” in the past, although a MCAD is the root cause of their histamine problems. We therefore recommend to all persons concerned to deal with this very new topic. Especially if there is no complete remission possible by leaving away histamine only.
Cookbook: now also available in ENGLISH
On the basis of the great success, the SIGHI Recipe Collection “mast-cell-friendly and low-histamine cooking”, available in German since September 2014, has now also been translated into English. Besides more than 180 cooking recipes it also contains a guide to diagnostic and therapeutic histamine elimination diet.
The book is aimed not only at histamine intolerant people. It was written especially for persons with a mast cell activation syndrome (MCAS). Unlike other cookbooks, not only histamine but also histamine liberators (liberators of mast cell mediators) are consistently avoided here. As a consequence, this diet restricts a little stronger than eliminating histamine only, but it still offers a tasty and well-balanced diet.
With many lactose-free and gluten-free recipes.
Our newsletter keeps you up to date.
The retrospective is a cronological list of the most important events in the past. It keeps you informed about our history.